Table 1 Comparison of prognosis and clinical baseline characteristics between the training and validation cohorts
Variables | Training cohort(n = 141) | Validation cohort(n = 61) | t/χ2/Z | P |
|---|---|---|---|---|
Age (years) | 70.05 ± 9.47 | 69.87 ± 7.30 | 0.133 | 0.894 |
Infarct volume (cm3) | 4.58(3.16,7.69) | 4.38(2.53,6.94) | -1.097 | 0.273 |
Gender (%) | Â | Â | 3.563 | 0.059 |
 Female | 43(30.5) | 27(44.3) |  |  |
 Male | 98(69.5) | 34(55.7) |  |  |
Hypertension (%) | Â | Â | 0.356 | 0.551 |
 No | 38(27.0) | 14(23.0) |  |  |
 Yes | 103(73.0) | 47(77.0) |  |  |
Hyperlipidemia (%) | Â | Â | 0.002 | 0.963 |
 No | 132(93.6) | 57(93.4) |  |  |
 Yes | 9(6.4) | 4(6.6) |  |  |
DM (%) | Â | Â | 0.263 | 0.608 |
 No | 99(70.2) | 45(73.8) |  |  |
 Yes | 42(29.8) | 16(26.2) |  |  |
CAD (%) | Â | Â | 1.418 | 0.234 |
 No | 97 | 47 |  |  |
 Yes | 44 | 14 |  |  |
Stroke history (%) | Â | Â | 0.454 | 0.500 |
 No | 72(51.1) | 28(45.9) |  |  |
 Yes | 69(48.9) | 33(54.1) |  |  |
Smoking history (%) | Â | Â | 0.097 | 0.755 |
 No | 101(71.6) | 45(73.8) |  |  |
 Yes | 40(28.4) | 16(26.2) |  |  |
Drinking history (%) | Â | Â | 0.807 | 0.369 |
 No | 105(74.5) | 49(80.3) |  |  |
 Yes | 36(25.5) | 12(19.7) |  |  |
Systolic blood pressure (mmHg) | 154.58 ± 22.60 | 152.25 ± 22.26 | 0.677 | 0.499 |
Diastolic blood pressure (mmHg) | 88.51 ± 12.69 | 86.62 ± 13.01 | 0.964 | 0.336 |
Admission blood glucose (mmol/L) | 7.15(5.26,8.79) | 6.77(5.13,8.62) | -0.703 | 0.482 |
HbA1c (%) | 6.10(5.75,7.30) | 6.30(5.70,7.65) | -0.563 | 0.574 |
TC (mmol/L) | 4.55(3.69,5.25) | 4.25(3.69,4.80) | -1.214 | 0.225 |
TG (mmol/L) | 1.28(0.87,1.76) | 1.22(0.83,1.83) | -0.222 | 0.825 |
HDL (mmol/L) | 1.17(0.97,1.34) | 1.10(0.88,1.22) | -1.993 | 0.056 |
LDL (mmol/L) | 2.77(2.02,3.34) | 2.52(2.04,3.02) | -1.459 | 0.145 |
HCY (µmol/L) | 13.79(11.28,18.94) | 12.09(10.28,18.31) | -1.467 | 0.142 |
Prognosis (%) | Â | Â | 0.047 | 0.828 |
 Good (mRS 0–2) | 74(52.5) | 31(50.8) |  |  |
 Poor (mRS 3–6) | 67(47.5) | 30(49.2) |  |  |